On November 1, IMS Health (the whole world is medicine and healthy industry provider bannerly the professional advisory corporation of trade news and solution) released market of drug of year whole world to forecast a report. The report of IMS is analysed, what global drug market rose 2008 is main because have,move the following at 3 o'clock: Of main disease domain medication cost drops; The contribution that ” of developing country of 7 “ medicine increases to global drug market will exceed the contribution of ” of developed country of 7 “ medicine first, the specialized subject will exceed wide general medicines and chemical reagents with development speed of medicine (Primary Care) ; The influence of the problem such as channel of the security that gets concerned drug, price, sale and intellectual property protection will have add without decrease.
Of IMS " global drug market and cure forecasted a report 2008 " point out, the increase rate of global medicine market predicted to be 6%~7% 2007, predicted to be 5%~6% 2008, the sale of global medicines and chemical reagents will achieve 735 billion ~7450 100 million dollars. This will be global medicine 40 old since growth rate of lowest, its are main the deficient that the reason is new drug and the intense price that come from copy pharmacy to taste compete.

IMS senior vice president Mr Murray Aitken points out, all sorts of phenomena make clear, 2008 will be a of global medicine market main turning point. Above all, 7 big “ drug of world developed the contributive rate of the increases sale of pair of global medicines and chemical reagents growth of market country ” will fall first 50% , and the contributive rate of ” of rising market country will obtain 7 “ drug 25% . Next, patent medicines and chemical reagents loses the speed of patent protection to will be accelerated further, the 370 billion ~3800 that has the place before bringing about these medical items the market sale of 100 million dollars glides quickly. The 3rd, biology medicines and chemical reagents and copy pharmacy taste enterprise general more the management mode that actively optimizes them, with period the new business chance that holds period of medical market transition.

The expert points out, was told 2008 to the patient should be a good news. Those who predict domain of a few main diseases medication cost will be reduced considerably, the patent protection of the main product that main reason is this domain perhaps been about to have expired, the copy pharmacy that makes low tastes a large number of invading. The product of afore-mentioned domains basically is: Hematic fat conditioning agent (Lipid Regulators) , calcic passageway retarder (element of Calcium Channel Blockers) , alternative serum absorbs depressor again (medicine of Selective Serotonin Reuptake Inhibitors) , osteoporosis (Osteoporosis Therapies) and proton pump depressor (Proton Pump Inhibitors) . Suffer afore-mentioned effects the biggest will be the United States, the data shows, the patent protection that waits for medicaments as a result of Nor Juan Vasc(r) , Zocor(r) and Zoloft(r) expires, these day of the United States that treat a field treated charge to drop 2007 20%~40% . Mr Aitken expresses, medicines and chemical reagents of predicting next year treats charge to will still continue to drop. With osteoporosis medicine and proton pump depressor two domains are exemple, because silent overcomes the Protonix(r) of the Fosamax(r) of the company and Whitworth company to will get,be modelled on medical competition, 2008, of these two domains medication charge may reduce 10%~25% .
Previous12 3 4 Next

Previous:Gram of pharmacy company silent wishs reparations end is in the beauty lawsuit o
Next：Did fourth flood of gas of A of decoct of photograph of of the same surname wide